鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/12 | 3,675 | 3,750 | 3,670 | 3,710 | +50 | +1.4% | 33,700 |
| 2024/01/11 | 3,675 | 3,700 | 3,650 | 3,660 | -25 | -0.7% | 47,500 |
| 2024/01/10 | 3,685 | 3,710 | 3,660 | 3,685 | +10 | +0.3% | 26,400 |
| 2024/01/09 | 3,680 | 3,695 | 3,655 | 3,675 | +25 | +0.7% | 30,100 |
| 2024/01/05 | 3,645 | 3,685 | 3,645 | 3,650 | +10 | +0.3% | 34,400 |
| 2024/01/04 | 3,565 | 3,640 | 3,540 | 3,640 | +85 | +2.4% | 28,200 |
| 2023/12/29 | 3,520 | 3,555 | 3,520 | 3,555 | +35 | +1% | 20,200 |
| 2023/12/28 | 3,535 | 3,535 | 3,505 | 3,520 | -80 | -2.2% | 20,500 |
| 2023/12/27 | 3,550 | 3,610 | 3,550 | 3,600 | +30 | +0.8% | 34,700 |
| 2023/12/26 | 3,585 | 3,595 | 3,565 | 3,570 | -15 | -0.4% | 19,400 |
| 2023/12/25 | 3,650 | 3,650 | 3,585 | 3,585 | -10 | -0.3% | 21,400 |
| 2023/12/22 | 3,560 | 3,625 | 3,545 | 3,595 | +65 | +1.8% | 32,000 |
| 2023/12/21 | 3,510 | 3,550 | 3,490 | 3,530 | -10 | -0.3% | 23,400 |
| 2023/12/20 | 3,535 | 3,575 | 3,535 | 3,540 | +15 | +0.4% | 27,600 |
| 2023/12/19 | 3,485 | 3,530 | 3,485 | 3,525 | +65 | +1.9% | 36,500 |
| 2023/12/18 | 3,460 | 3,475 | 3,415 | 3,460 | +25 | +0.7% | 29,700 |
| 2023/12/15 | 3,505 | 3,510 | 3,420 | 3,435 | -85 | -2.4% | 53,200 |
| 2023/12/14 | 3,565 | 3,590 | 3,495 | 3,520 | -60 | -1.7% | 44,600 |
| 2023/12/13 | 3,565 | 3,590 | 3,525 | 3,580 | +20 | +0.6% | 33,200 |
| 2023/12/12 | 3,630 | 3,655 | 3,555 | 3,560 | -70 | -1.9% | 32,800 |
| 2023/12/11 | 3,615 | 3,640 | 3,605 | 3,630 | +25 | +0.7% | 30,700 |
| 2023/12/08 | 3,670 | 3,670 | 3,585 | 3,605 | -70 | -1.9% | 42,000 |
| 2023/12/07 | 3,710 | 3,710 | 3,660 | 3,675 | -45 | -1.2% | 29,600 |
| 2023/12/06 | 3,700 | 3,750 | 3,665 | 3,720 | +60 | +1.6% | 32,000 |
| 2023/12/05 | 3,675 | 3,720 | 3,655 | 3,660 | -60 | -1.6% | 18,500 |
| 2023/12/04 | 3,725 | 3,730 | 3,635 | 3,720 | -30 | -0.8% | 39,700 |
| 2023/12/01 | 3,705 | 3,760 | 3,700 | 3,750 | +90 | +2.5% | 72,100 |
| 2023/11/30 | 3,650 | 3,720 | 3,570 | 3,660 | +10 | +0.3% | 100,300 |
| 2023/11/29 | 3,660 | 3,665 | 3,635 | 3,650 | ±0 | ±0% | 16,900 |
| 2023/11/28 | 3,595 | 3,655 | 3,570 | 3,650 | +85 | +2.4% | 49,400 |
| 2023/11/27 | 3,635 | 3,635 | 3,535 | 3,565 | -80 | -2.2% | 36,600 |
| 2023/11/24 | 3,665 | 3,665 | 3,640 | 3,645 | -15 | -0.4% | 14,500 |
| 2023/11/22 | 3,600 | 3,660 | 3,595 | 3,660 | +80 | +2.2% | 30,500 |
| 2023/11/21 | 3,600 | 3,630 | 3,560 | 3,580 | -35 | -1% | 21,700 |
| 2023/11/20 | 3,640 | 3,645 | 3,605 | 3,615 | -20 | -0.6% | 16,800 |
| 2023/11/17 | 3,610 | 3,645 | 3,580 | 3,635 | +25 | +0.7% | 31,000 |
| 2023/11/16 | 3,580 | 3,645 | 3,550 | 3,610 | +55 | +1.5% | 35,400 |
| 2023/11/15 | 3,545 | 3,575 | 3,535 | 3,555 | +10 | +0.3% | 22,000 |
| 2023/11/14 | 3,610 | 3,610 | 3,545 | 3,545 | -45 | -1.3% | 17,400 |
| 2023/11/13 | 3,650 | 3,650 | 3,580 | 3,590 | -55 | -1.5% | 14,200 |
| 2023/11/10 | 3,605 | 3,650 | 3,590 | 3,645 | +65 | +1.8% | 24,900 |
| 2023/11/09 | 3,595 | 3,595 | 3,555 | 3,580 | -15 | -0.4% | 12,500 |
| 2023/11/08 | 3,605 | 3,625 | 3,560 | 3,595 | -20 | -0.6% | 27,700 |
| 2023/11/07 | 3,625 | 3,665 | 3,595 | 3,615 | -10 | -0.3% | 30,800 |
| 2023/11/06 | 3,630 | 3,680 | 3,620 | 3,625 | +15 | +0.4% | 41,500 |
| 2023/11/02 | 3,580 | 3,610 | 3,550 | 3,610 | +85 | +2.4% | 48,200 |
| 2023/11/01 | 3,570 | 3,630 | 3,485 | 3,525 | -115 | -3.2% | 61,800 |
| 2023/10/31 | 3,600 | 3,640 | 3,545 | 3,640 | +85 | +2.4% | 56,500 |
| 2023/10/30 | 3,665 | 3,665 | 3,530 | 3,555 | -105 | -2.9% | 41,800 |
| 2023/10/27 | 3,635 | 3,660 | 3,610 | 3,660 | +10 | +0.3% | 20,800 |
301～
350
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 435,500円 | +7.1% | -35.0% | 2.76% | 36.01倍 | 1.01倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 371,500円 | +14.5% | -2.3% | 2.42% | 13.59倍 | 0.72倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 253,000円 | +15.0% | -7.3% | 2.77% | 8.30倍 | 0.78倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 222,900円 | +14.2% | +41.0% | 2.06% | 10.92倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
